~

CHEMOPHARMALABORATORIES
LIMITED
Registered Office: 5-Kumud Apartment Co. Op. HSG. Sac. Ltd., Karnik Road, Chikan Ghar, Kalyan, Dist. Thane - 421301
. CorporateOffice: - Empire House, 3'dPloor, 214, Dr. D. N. Road, Port, Mumbai - 400 001

. Tel.No. (022)22078381,22078382. Pax No.: (022)22074294' CIN No.: L99999MH1942PLCO03556PAN

Website: www.thechemopharmalaboratoriesltd.com

No.: AAACC2056K

Email ID:chemopharmalab@gmail.com

Date: 23rd January,

To,
Bombay Stock Exchange Ltd.
Department
of Corporate Services
25th Floor, P.J.Towers, Dalal Street,
Mumbai-400 001

Script ID

2017

506365

SUBMISSION OF COMPLIANCES UNDER SECURITIES AND EXCHANGE BOARD

OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS)
REGULATIONS. 2015

Subject

Dear Sirs,

We are enclosing herewith Quarterly Compliances pursuant to Securities And Exchange

Board of India (Listing Obligations And' Disclosure Requirements) Regulations, 2015 for
Quarter ended 31st December, 2016 as under-

1.

Un-audited Quarterly Financial Results, for the Quarter ended

31/12/2016
along with Limited Review Report issued by our
Auditors, M/s. VMD & Co, Chartered Accountant, Mumbai

Regulation 33
.'

2.

You are requested

Outcome

of the Board Meeting

to take this on your records.

Thanking You.
Yours Faithfully,
FOR CHEMO PHARMA LABORATORIES LIMITED

"
,.

ASHOK SOMANI
DIRECTOR
(DIN NO. - 03063364)

Held on 23/01/2017

CHEMO
PHARMA
lABORATORIES
liMITED

REGISTERED

OFFICE: 5-KUMUD

APARTMENT

CO. OP. HSG. SOc. LTD., KARNIK

ROAD,CHIKAN

GHAR,

KAL YAN, DIST. THANE-

421301

. CORPORATEOFFICE-EMPIREHOUSE, 3'DFLOOR, 214, DR. D. N. ROAD, FORT,MUMBAI- 400001

TEL NO.: (022) 22078381, 22078382

CIN NO.: L99999MH1942PLCO03556

. FAX NO.: (022)22074294

PAN NO.: AAACC2056K

WEB SITE: www.thechemopharmalaboratoriesltd.com

EMAIL ID:chemopharmalab@gmail.com

UNAUDITED FINANCIAL RESULTS

FOR THE QUARTER AND NINE MONTHS ENDED ON 31ST DECEMBER, 2016
(Rs. in Thousand)
STANDLONE

Quarter
Sr.
No.

Particulars

Income
Crom Operations
(a) Net Sales/ Income from Operations
(b) Other Operating Income
Total Income Crom operations

Expenses
(a) Cost of materials
(b) Purchases

(net)

Unaudited

Unaudited

Audited

552

1,490

326

2,967

2,374

4,919

552

1,490

326

2,967

2,374

4,919

191
-

191
-

152
-

571
-

392
-

542
-

207

156

18

401

178

354

191

79

36

290

136

476

35

18

66
256
1,584

72
235
1,013

116
245

443

35
10
251

1,733

1,047

75

1,382

1,361

3,186

and amortisation

Profit I Loss Crom Operation

Finance cost and exceptional
Other Income

expense

624
(72)

beCore other Income,

items (1-2)

5 Profit ILoss Cromordinary activities beCore

7

Finance cost and exceptional items (3+4)

Finance Costs
after Finance
Profit / Loss Crom ordinary activities

cost but be Core exceptional

Exceptional Items

items (5+6)

Net Profit/(Loss) Crom ordinary activities beCore tax

7+81
10 Tax expenses
11 Net Profit/(Loss) Crom ordinary activities
after tax
9+101
12 Extra ordinary items (net of tax expenses Rs.
)

Net Profitl (Loss) Corthe period (11+121

Share of ProfItl (Loss)of associate'
Minority interest'

Net Profit I (Loss) after taxes, minority interest and share

oCprofit I (loss) oCassociates 13+14+15)*
17 Paid-up equity share Capital (face value of Rs. 10/- each)
18 Reserves excluding revaluation reserve as per
balance sheet of nrevious accounting vear
items)
19 i) Earning
(beCore extraordinary
per share
oCRs. 10/- each) (not annualised):
'.
(a) IBasic
(b) IDiluted
19 ii) Earning
(after extraordinary
per share
ocns. 10/- each) (not annualised):
(a) IBasic

Unaudited

ii) Share Registry Expenses

ill) Annual Listing Fees
Total Expenses

13
14
15
16

Unaudited

Year Ended
31st March,
2016

(f) Other expenses (Any item exceeding 10% of the total

expenses relating to continuing operations to be
shown seperatelv)
i) Professional Charges

Unaudited

31st Dec.,
2015

consumed

(e) Depreciation

30th Sept.,
2016

Ended

31st Dec.,
2016

of Stock-in-trade

(c) Change in inventories of fInished goods,

work-in-progress and stock-in-trade
(d) Employee benefIts expenses

31st Dec.,
2016

31st Dec.,
2015

(Net of excise

Nine Months

Ended

'*

(72)

1,047

75

(721

1,382

(72)

1,047

1,361

3,186

1,382

1,361

3,186

1,361

3,186

75

1,047

75

1,382

(72)

1,047

75

1,382

1,361

(72)
-

1,047
-

75
-

1,382
-

1,361
-

2,168

(72)

1,047

75

1,382

1,361

2,168

1,018
2,168

15,000

15,000

15,000

15,000

15,000

15,000

38,385

38,385

37,503

38,385

37,503

38,385

(0.05)

0.70

0.05

0.92

0.91

1.45

(0.05)

0.70

0.05

0.92

0.91

1.45

items)

(b) IDiluted

,:~~
,. "."'"
'-.
80
f!0
II~""'-

~
.

~\

~-\.

AVO\

\i~
~ !
\" '"
;;; i
.-S-':--"
.v
-, .;""..." ,
'.~-!
~ .
.

.
CHEMOPHARMALABORATORIES
LIMITED

f'

REGISTERED OFFICE: 5-KUMUD APARTMENT CO. OP. HSG. SOc. LTD., KARNIK ROAD,CHIKAN GHAR, KALYAN, DIST. THANE- 421301

. CORPORATEOFFICE-EMPIREHOUSE, 3'DFLOOR, 214, DR. D. N. ROAD, FORT, MUMBAI - 400

..

001

TEL NO.: (022) 22078381, 22078382 . FAX NO.: (022)22074294

CIN NO.: L99999MH1942PLCOO3556 PAN NO.: AAACC2056K
WEB SITE: www.thechemopharmalaboratoriesltd.com
EMAIL ID:chemopharmalab@gmail.com

PARTICULARS OF SHAREHOLDING

Public Shareholding
- Number of shares
- Percentage

19 Promoters

10,81,719
'/2.12

of shareholding

1\),81,719
72.12

10,81,719
72.12

10,81,719
72.12

10,81,719
72.12

and Promoter Group shareholding**

a) Pledged/Encumbered
- Number of shares

- Percentage

of shares (as a % of the total shareholding of

promoter and promoter !!roup!
- Percentage of shares (as a % of the total share capital of
comnanv)
b) Non-Encumbered
- Number of shares

- Percentage
,

10,81,719
72.12

of shares (as a % of the total shareholding

of

NIL

NIL

NIL

NIL,

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

4,18,281
100

4,18,281
100

promoter and promoter !!rouP)

'- Percentage of shares (as a % of the total share capital of
comnanv!

27.88

27.88

4,18,281
100

27.88

4,18,281
100

4,18,281
100

4,18,281
100

27.88

27.88

27.88

Note:

The above Un-Audited Financial Results for the quarter and nine months ended 31.12.2016 have been reviewed by the Audit
Committee in their Meeting held on 23.01.2017 and approved by the Board of Directors ofits Meeting held on 23.01.2017. The
Limited Review Report of Auditors Mis VMD & Co. was also taken on record by the Board in its Meeting.
2

The Company is having Associate Company and these are Standalone

Results as intimated to BSE

For Chemo

Place:
Date:

Mumbai
23rd January,

2017

,.

By Order of the Board

Laboratories Limited

- Pharma

~'Director

VMD &

co.

AVMS PREMISES,
4THFLOOR,
SHREENIWAS HOUSE,
27, H.S. MARG, FORT,
MUMBAI- 400 001
Telefax: +91 22 2207 7707
Email: info@vmd.co.in
www.vmd.co.in

CHARTERED ACCOUNTANTS

LIMITED REVIEW REPORT

~
We have reviewed the accompanying Statement of unaudited financial results of MIS CHEMOPHARMA
LABORATORIESLTD., Mumbai for the quarter ended 31st December; 2016.

This Statement is the

responsibility of the Company's management and has been approved by the Board of Directors

committee of Board of Directors. Our responsibilityis to issue a report on these financialstatements based
on our review.

We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400,
Engagement to Review Financial Statements issued by the Institute-of Chartered Accountants of India.
This stanpard requires that we plan and perform the review to obtain moderate assurance as to whether
the financial statements are free of material misstatement. A review is limited to inquiries of company
personnel and analytical procedures applied to financial data and thus provide less assurance than an
audit. We have not performed an audit and accordingly,we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our notice that causes us to believe that
the accompanying Statement of unaudited financial results prepared in accordance with applicable
Accounting Standards and other recognized accounting practices and polices has not disclosed the
information required to be disclosed in terms of Clause 41 of the ListingAgreement includingthe manner
in which it is to be disclosed, or that it contains any material misstatement.

For Mjs VMD & CO.

Chartered Accountants.
FRN: 125002W

kVZG=E

NO: Cj04jOl17
Dated:'2.."!j01j2017
Place: MUMBAI
,.

PARTNER

MRN: 114222

"